Option chain shows key data for Scinai Immunotherapeutics's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Scinai Immunotherapeutics.

Scinai Immunotherapeutics (NASDAQ:SCNI) Stock, Option Chain

Scinai Immunotherapeutics

Scinai Immunotherapeutics Ltd is a biopharmaceutical company focused on developing, manufacturing and commercializing products for the prevention and treatment of infectious diseases and other illnesses. It has executed eight clinical trials in seven countries, around 12,400 participants in the Phase 3 trial of its vaccine candidate and has built a GMP biologics manufacturing facility for biopharmaceutical products. The company is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with a nanosized antibody (NanoAb) pipeline.

movers image

News

Intraday Update

Markets

Movers

Trading Ideas

ADTX

ADVM

AEHR

ALLR

AMIX

APVO

ASLN

ASML

ASST

CLIR

CRDO

CYCN

FDMT

FIVE

FUBO

GPCR

GTLB

HNST

JBHT

LAZR

LCFY

NAAS

NVDA

NVMI

OCTO

ONTO

QCOM

SAVA

SAVE

SCNI

SHIM

SIEB

SMTC

SNAP

SONM

TKNO

VKTX

VRPX

Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday&#39;s Mid-Day Session

Crude Oil 6- logo

Eurozone

Commodities

LXEO

VTAK

Crude Oil Moves Lower; Goldman Sachs Posts Upbeat Results

Image49

AEON

AGRI

AREB

ASTL

COIN

DATS

EAST

FSLR

FUFU

HUMA

INOD

KZIA

LCID

MIRA

MLEC

MSTR

NOVA

PETZ

POWW

Qualigen Therapeutics, Inc. - Common Stock

QLGN

SEDG

SQNS

TSLA

UPST

Why SolarEdge Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Monday&#39;s Mid-Day Session

Scinai Immunotherapeutics Ltd. - American Depositary Shares

Scinai Immunotherapeutics Ltd

Small Cap

Press Releases

Scinai Regains Full Compliance with Nasdaq Listing Requirements

General

IBN Announces Latest Episode of The BioMedWire Podcast featuring Amir Reichman, CEO of Scinai Immunotherapeutics Ltd.

Scinai to Host Online Expert Panel on Plaque Psoriasis Treatment and Intralesional Injections of anti-IL-17A/F VHH Antibodies

Scinai Leadership to Showcase Company's cGMP Biologics CDMO and Innovative I&I pipeline during BIO-Europe 2024

Earnings

Scinai Publishes Financial Results and Provides Business Update; Shareholders' Equity up from negative $7.3 million as of June 30, 2024, to positive $10 million

Dr. Jonathan Sadeh, Former Senior Vice President of Immunology R&D at Bristol-Myers Squibb, Joins Scinai Immunotherapeutics' Scientific Advisory Board

Prof. Michael Schön, Director of Dermatology and Venereology at the University Medical Center Göttingen, Germany (UMG), Joins Scinai Immunotherapeutics' Scientific Advisory Board

Scinai Immunotherapeutics Establishes U.S. Subsidiary for CDMO Business Unit, Scinai Bioservices Inc.

Scinai to Connect with Investors and Pharma Leaders at Upcoming Key US Conferences

SCINAI IMMUNOTHERAPEUTICS ANNOUNCES $10 MILLION STANDBY EQUITY PURCHASE AGREEMENT

Aditxt

Aptevo Therapeutics

AquaBounty Technologies, Inc. - Common Stock

AquaBounty Techs

180 Life Sciences

Entero Therapeutics

Genprex

GRI Bio

Lipella Pharmaceuticals Inc. - Common Stock

Lipella Pharmaceuticals

Lixte Biotechnology Holdings, Inc. - Common Stock

Lixte Biotechnology

Mustang Bio

Matinas Biopharma Holdings, Inc. Common Stock

Matinas BioPharma Hldgs

Oragenics

Onconetix

Palisade Bio

Psyence Biomedical Ltd. - Ordinary Shares

Psyence Biomedical

Polyrizon

Protagenic Therapeutics, Inc. - Common Stock

Protagenic Therapeutics

Qualigen Therapeutics

Quoin Pharmaceuticals, Ltd. - American Depositary Shares

Quoin Pharmaceuticals

Synaptogenix

Syros Pharmaceuticals, Inc. - Common Stock

Syros Pharmaceuticals

Alaunos Therapeutics, Inc. - Common Stock

Alaunos Therapeutics

Tharimmune

Theriva Biologics

ZyVersa Therapeutics, Inc. - Common Stock

ZyVersa Therapeutics

Comments

Scinai Immunotherapeutics

Scinai Immunotherapeutics (SCNI) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga